CRP and atherosclerosis: Treatment strategies based on hsCRP levels have resulted in reduced CVD events,176 and hsCRP levels are used to re‐classify patients with intermediate ASCVD risk currently.25 However, CRP levels were decreased in HCV patients compared to uninfected patients in many35, 98, 99, 157, 163 but not all studies.34, 102, 158, 159, 163 Inconsistencies in results may be due to differences in patient populations, study designs and types of assay used.